Litigation Details for MITSUBISHI TANABE PHARMA CORPORATION v. SANDOZ INC. (D.N.J. 2017)
✉ Email this page to a colleague
MITSUBISHI TANABE PHARMA CORPORATION v. SANDOZ INC. (D.N.J. 2017)
Docket | ⤷ Try a Trial | Date Filed | 2017-07-20 |
Court | District Court, D. New Jersey | Date Terminated | |
Cause | 15:1126 Patent Infringement | Assigned To | Freda L. Wolfson |
Jury Demand | None | Referred To | |
Patents | 7,943,788; 8,222,219; 8,785,403 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in MITSUBISHI TANABE PHARMA CORPORATION v. SANDOZ INC.
Details for MITSUBISHI TANABE PHARMA CORPORATION v. SANDOZ INC. (D.N.J. 2017)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2020-06-15 | 173 | Opinion | infringement of U.S. Patent Nos. 7,943,788 (“the ’788 patent), 8,222,219 (“the ’219 patent), and 8,785,403… (“the ’403 patent”) (collectively, “the patents-in-suit”). Compl. at ¶ 10. The patents-in-suit are… B. Local Patent Rules Pursuant to the Local Patent Rules for the District of…Local Patent Rules. Zydus contends that the “priority date” disclosure required by Local Patent Rule….D. Cal. July 17, 2015) (“Patent L.R. 3-1(f) particularly requires a patent holder to assert a specific | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |